Abstract
Two clinical Streptococcus pneumoniae isolates, identified as resistant to macrolides and chloramphenicol and nonsusceptible to linezolid, were found to contain 6-bp deletions in the gene encoding riboprotein L4. The gene transformed susceptible strain R6 so that it exhibited such resistance, with the transformants also showing a fitness cost. We demonstrate a novel bacterial mechanism of resistance to chloramphenicol and nonsusceptibility to linezolid.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents / pharmacology*
-
Chloramphenicol / pharmacology
-
Drug Resistance, Multiple, Bacterial / genetics*
-
Humans
-
Macrolides / pharmacology
-
Microbial Sensitivity Tests
-
Mutation*
-
Oxazolidinones / pharmacology
-
Ribosomal Proteins / genetics*
-
Streptococcus pneumoniae / drug effects*
-
Streptococcus pneumoniae / genetics
-
Streptococcus pneumoniae / growth & development
Substances
-
Anti-Infective Agents
-
Macrolides
-
Oxazolidinones
-
Ribosomal Proteins
-
ribosomal protein L4
-
Chloramphenicol